Takeda links with US medical groups for obesity drug research
This article was originally published in Scrip
Executive Summary
In a signal of its increasing interest in the sector, Takeda has entered into a two-year collaboration with two medical institutions in the US to investigate and develop novel approaches to the treatment of obesity.